CRISPR-Cas9 genome editing ... models of the mutagenic outcomes of Cas9 scission. Red light optogenetic systems are in high demand for therapeutic applications. Here, the authors introduce REDLIP ...

CRISPR/Cas9 Modifies Euglena to Create Potential Biofuel Source Sep. 13, 2024 — Through genome editing using CRISPR/Cas9, researchers stably create euglena mutants that can produce wax esters ...

Distinct from the CRISPR-Cas9 system, the spokesperson added is that the development time of CRISPR-Cas3 assets can be advanced “in half the time and at a fraction of the cost of traditional ...

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics ... rapid validation as sales of its covid vaccine soared in 2021 and 2022, but ...

Crispr Therapeutics is a clinical-stage gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly ...

A new study by the World Health Organization (WHO) lists 17 bacteria, viruses and parasites that regularly cause disease as top priorities for new vaccine development. The study is the first global ...

The study reconfirms longstanding priorities for vaccine research and development, including HIV, malaria and tuberculosis -- three diseases that collectively kill nearly 2.5 million people each ...

A WHO report reconfirms longstanding priorities for vaccine research and development, including HIV, malaria and tuberculosis but also identifies lesser-known pathogens as top disease control ...